.png){kind=icon}
.png){kind=icon}
Return
Breast Cancer, Version 3.2022
.png){kind=icon}
OA
AI
DOI：10.6004/jnccn.2022.0030.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The therapeutic options for patients with noninvasive or invasive breast cancer are complex and varied. These NCCN Clinical Practice Guidelines for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget disease, phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of ductal carcinoma in situ and the workup and locoregional management of early stage invasive breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org. J Natl Compr Canc Netw 2022;20(6):691-722 doi: 10.6004/jnccn.2022.0030
Keywords:
CARCINOMA-IN-SITU
SURGICAL ADJUVANT BREAST
LYMPH-NODE DISSECTION
CONTRALATERAL PROPHYLACTIC MASTECTOMY
20-YEAR FOLLOW-UP
QUALITY-OF-LIFE
POSTMASTECTOMY RADIATION IMPROVES
INTENSITY-MODULATED RADIOTHERAPY
ONCOLOGY CONSENSUS GUIDELINE
RANDOMIZED CONTROLLED-TRIAL
Journal
J
IF:
16.4
Papers:
2.8K
Citations:
1.5W
Organization
View more organizations